Transformation

Introduction In the pharmaceutical industry, supply chains are no longer viewed as operational backbones that quietly support manufacturing and distribution. For large, global pharmaceutical enterprises, the supply chain is a strategic asset that directly influences regulatory compliance, product availability, revenue protection, and corporate reputation. Increasing regulatory scrutiny, globalized sourcing models, complex biologics portfolios, and heightened…